Cannabinoid

Marijuana has implications for weight and metabolism — but perhaps not in the ways one might expect, according to a speaker at the 2022 Overcoming Obesity conference.

A biopharmaceutical company has announced positive interim data from the first two cohorts in an ongoing phase 2 clinical trial of its treatment for acute cannabinoid intoxication.

Cannabinoids are widely available for therapeutic and recreational use, but data are limited regarding drug-drug interactions — particularly with cardiovascular medications, according to experts.

The role and status of cannabis in the United States have evolved both medically and legally. In 2020, 49.6 million people in the United States reported using a form of cannabis in the previous year.

In this edition, new cannabinoids hold promise for medical applications; Theranica secures $45 million for migraine treatment device and more.

LAS VEGAS — Lesser-known cannabinoids are showing potential for treating neurological disease, inflammation, pain, cancer and infection, according to dermatologist Jeanette Jacknin, MD.

Researchers found that topical CBD products purchased online and in retail stores were often inaccurately labeled, and many contained THC, highlighting the need for improved regulatory oversight, according to a report in JAMA Network Open.

Transdermal CBD was well tolerated and safe among those with drug-resistant focal epilepsy, although no efficacy was observed compared with placebo during a 12-week treatment period, researchers reported in JAMA Network Open.

DENVER — There may be a link between migraine and clinical endocannabinoid deficiency, a speaker said at the American Headache Society’s annual scientific meeting.

Last week, Healio provided live coverage of Digestive Disease Week, which was held in person for the first time in 2 years.